ASND icon

ASND

Lightning icon

231.99 USD

+3.73%

Today

+3.76%

1D

Market is open

Sun

Closed

Mon

4:30 PM ~ 11:00 PM

Tue

4:30 PM ~ 11:00 PM

Wed

4:30 PM ~ 11:00 PM

Thu

4:30 PM ~ 11:00 PM

Fri

Closed

Sat

Closed

Loading chart...
1D
5D
1M
3M
1Y
MAX

Information

Name

Ascendis Pharma A/S Leveraged

Currency

USD

Standard Leverage

1X

Lightning Icon

Enhanced Leverage

3X

Lightning Icon

Overnight Fees Buy

-0.0183%

Overnight Fees Sell

0.0016%

Market Cap

14.14B

Avg Daily Volume

623.51K

52 Week High

250.74 USD

52 Week Low

160.86 USD

Trading Hours

See hours

Overnight Fees Calculator

ExposureUnits
USD
Daily Overnight Fee %Daily Overnight Fee $
BUYS-0.01830%$(0.183)
SELLS0.00160%$0.016

*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.

Business Summary

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

Top News

Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism

tradingview.com

2d ago

No Image

Ascendis to Showcase Advances in Treatment of Rare Endocrine Diseases at ENDO 2026

tradingview.com

1w ago

No Image

Ascendis Pharma Reports First Quarter 2026 Financial Results

tradingview.com

1mo ago

No Image

Show more

Frequently Asked Questions

What are healthcare stocks and why are they important to investors?

Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.


Are healthcare stocks less volatile?

Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.


What drives growth in healthcare investments?

Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.


What are the risks of investing in healthcare?

Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.